ng-nitroarginine methyl ester and Disease Exacerbation

Topics: Animals; Calcinosis; Calcium; Disease Progression; Endothelial Cells; Male; NG-Nitroarginine Methyl Ester; Rats; Tunica Media; Vascular Calcification; Vascular Diseases; Warfarin

Topics: Animals; Atherosclerosis; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Disease Progression; Foam Cells; Humans; Inflammation; Lipoproteins, LDL; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I

Topics: Adaptation, Physiological; Animals; Chemical and Drug Induced Liver Injury; Disease Progression; Eating; Enzyme Inhibitors; Inflammation Mediators; Insulin Resistance; Lipids; Liver; Liver Cirrhosis, Experimental; Macrophages; Mitochondria, Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Non-alcoholic Fatty Liver Disease; Obesity; Rats, Inbred OLETF; Time Factors

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Cell Proliferation; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Enalapril; Enzyme Inhibitors; Interleukin-10; Interleukin-6; Macrophages; Male; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred SHR

Topics: Acetylcholine; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Chemokines; Cyclic N-Oxides; Cyclooxygenase 2; Disease Progression; Endothelium, Vascular; Immunization; Inflammation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Nitroprusside; Osteoprotegerin; Radiography; Rats, Inbred Lew; Spin Labels; Sulfonamides; Superoxides; Time Factors; Vasoconstriction; Vasodilation

Topics: Aconitate Hydratase; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Gel, Two-Dimensional; Humans; Immunohistochemistry; Mice; NG-Nitroarginine Methyl Ester; Protein Structure, Quaternary; Proteins; Proteomics; Reproducibility of Results; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spinal Cord; Stress, Physiological; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine

Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Guanylate Cyclase; Heart; Hypertension; Kidney; Longevity; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrazoles; Pyrimidines; Rabbits; Rats; Rats, Wistar; Renin; Signal Transduction

Topics: Adenocarcinoma; Animals; Arginine; CD11b Antigen; Cell Proliferation; Disease Progression; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelopoiesis; NG-Nitroarginine Methyl Ester; Piperazines; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; T-Lymphocytes; Tumor Cells, Cultured

Topics: Animals; Biomarkers; Blood Pressure; Cell Adhesion Molecules; Disease Progression; Gene Expression Regulation; Humans; Hypertension; Kidney Diseases; Kidney Transplantation; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transplantation, Homologous; Vascular Diseases

Topics: Acetylcholine; Animals; Aorta; Arteries; Body Weight; Cholesterol; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Laser-Doppler Flowmetry; Lipids; Male; Mice; Mice, Inbred C57BL; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside

Topics: Acridines; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Coronary Artery Disease; Coronary Vessels; Cyclic GMP; Disease Progression; Luminescent Measurements; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Peptidyl-Dipeptidase A; Time

Topics: Animals; Cardiac Output; Disease Progression; Enzyme Inhibitors; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Random Allocation; Ventricular Function, Left; Ventricular Remodeling

Topics: Acute Kidney Injury; Animals; Benzamides; Contrast Media; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Indomethacin; Kidney Function Tests; Kidney Medulla; Kidney Tubules; Male; Necrosis; NG-Nitroarginine Methyl Ester; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Treatment Outcome

Topics: Adrenergic beta-Agonists; Animals; Aorta; Cattle; Caveolin 1; Caveolins; Cell Line; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Progression; Dopamine; Down-Regulation; Glycosuria; Humans; Hyperglycemia; Isoproterenol; Mice; Mice, Inbred NOD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Receptor, Insulin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Serotonin; Vasodilation

Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents

Topics: Acetylcysteine; Animals; Antioxidants; Collagen; Disease Progression; Drug Evaluation, Preclinical; Glutathione; Heart Ventricles; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Sodium Chloride, Dietary; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling

Topics: Aging; Animals; Aorta; Atherosclerosis; Blood Pressure; Body Weight; Cholesterol; Disease Progression; Electrocardiography; Enzyme Inhibitors; Hyperlipoproteinemia Type V; Hypertension; Lipids; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rabbits; Triglycerides

Topics: Acetylcholine; Age Factors; Animals; Aorta, Abdominal; Aorta, Thoracic; Calcium; Cyclic GMP; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Enzyme Inhibitors; Fibrillin-1; Fibrillins; Marfan Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Vasodilation; Vasodilator Agents

Topics: Alanine Transaminase; Animals; Bronchoalveolar Lavage Fluid; Capillaries; Carboxyhemoglobin; Cytokines; Disease Progression; Endotoxemia; Enzyme Inhibitors; Guanidines; Heme Oxygenase (Decyclizing); Hepatopulmonary Syndrome; Intestinal Diseases; Lipopolysaccharides; Liver; Liver Cirrhosis, Experimental; Lung; Male; Malondialdehyde; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Portal Pressure; Protoporphyrins; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Up-Regulation

Topics: Animals; Arterioles; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Endothelin-1; Enzyme Inhibitors; Hypertension; Insulin; Isoproterenol; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Potassium Chloride; Prediabetic State; Rats; Rats, Zucker; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

Topics: Animals; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Culture Media, Serum-Free; Disease Progression; Embryonic Stem Cells; Enzyme Inhibitors; Female; Genes, myc; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Models, Biological; Neoplasms, Germ Cell and Embryonal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proto-Oncogene Proteins p21(ras); Tumor Burden; Tumor Necrosis Factor-alpha

Topics: Animals; Disease Progression; Enzyme Inhibitors; Female; Leukemia Virus, Murine; Lymphocyte Activation; Lymphocyte Subsets; Macrophages; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Organ Size; Spleen; T-Lymphocytes; Virus Replication

Topics: Adult; Aged; Carcinoma, Squamous Cell; Cyclic GMP; Disease Progression; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Transcription, Genetic; Tumor Cells, Cultured

Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic beta-Agonists; Animals; Apamin; Blood Pressure; Calcium; Diclofenac; Disease Progression; Endothelium, Vascular; Female; Hypertension; In Vitro Techniques; Isoproterenol; Male; Mesenteric Artery, Superior; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Sex Characteristics; Vasoconstriction

Topics: Animals; Arginine; Bacteremia; Biological Transport; Cell Membrane; Critical Illness; Disease Progression; Enzyme Inhibitors; Guanidines; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Rats; Rats, Sprague-Dawley

Topics: Animals; CD3 Complex; Cell Division; Cytotoxicity, Immunologic; Disease Progression; Enterotoxins; Glioma; Immune Tolerance; Injections, Intraperitoneal; Kinetics; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred F344; Spleen; Superantigens; T-Lymphocytes; Tumor Cells, Cultured

Topics: Acetylcholine; Animals; Aorta; Apolipoproteins E; Arginine; Arteriosclerosis; Blood Pressure; Disease Progression; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Nitroprusside; Vasoconstriction

Topics: Animals; Apoptosis; Body Weight; Cathepsin D; Cell Count; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Intestine, Small; Isothiuronium; Macrophages; Mice; Mice, Knockout; Microglia; Neuronal Ceroid-Lipofuscinoses; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phagocytosis; Thalamus

Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

Topics: Animals; Arteries; Disease Progression; Endothelial Growth Factors; Enzyme Inhibitors; Kidney Glomerulus; Lymphokines; Male; Mice; Microcirculation; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Postoperative Period; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors